Robert A Kay

US Patent:

6767899, Jul 27, 2004

Filed:

Aug 29, 2000

Appl. No.:

09/650055

Inventors:

Robert A. Kay - LaMirada CA
Larry K. Thomas - Irvine CA
Beuford A. Bogue - Carson CA

Assignee:

Leiner Health Services Corp. - Carson CA

International Classification:

A61K 3170

US Classification:

514 62, 424461, 536 552

Abstract:

Compositions and methods of treatment for conditions in humans and animals which have an inflammatory component, are disclosed. The composition comprises a glucosamine component dispersed in a controlled-release matrix system capable of releasing the glucosamine over a designated time period. In another aspect, the invention provides compositions and methods for the treatment of arthritis in humans and animals without adversely effecting glucose regulation.

US Patent:

6887492, May 3, 2005

Filed:

Dec 14, 2001

Appl. No.:

10/017478

Inventors:

Robert A. Kay - LaMirada CA, US
Larry K. Thomas - Irvine CA, US

Assignee:

Leiner Health Services Corp. - Carson CA

International Classification:

A61K009/28
A61K009/20
A61K009/22
A61K009/48
A61K009/24

US Classification:

424474, 424464, 424468, 424463, 424451, 424457, 424472

Abstract:

The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium component which has an enteric coating that controls the release of the magnesium until the composition is in the small intestine or colon. The other component is released in the stomach and is substantially absorbed prior to the release of the magnesium component. Normally, the interactive agent component decreases the absorption of magnesium when the two components are released simultaneously in the gastrointestinal tract.

US Patent:

7338942, Mar 4, 2008

Filed:

Jun 9, 2004

Appl. No.:

10/865404

Inventors:

Robert A. Kay - LaMirada CA, US
Larry K. Thomas - Irvine CA, US
Beuford A. Bogue - Carson CA, US

Assignee:

Leiner Health Services, Corp. - Carson CA

International Classification:

A61K 31/715
A61K 31/70

US Classification:

514 54, 514 62, 562 552, 424461

Abstract:

Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a controlled-release matrix system capable of releasing the glucosamine and chondroitin over a designated time period. In another aspect, the invention provides compositions and methods for maintaining health mobile joints and cartilage in humans and animals without adversely affecting glucose regulation.

US Patent:

20030022206, Jan 30, 2003

Filed:

May 15, 2002

Appl. No.:

10/146661

Inventors:

Robert Kay - Brea CA, US

International Classification:

C12Q001/68
A61K035/78
A61K033/00

US Classification:

435/006000, 424/600000, 424/725000

Abstract:

A method is provided for obtaining a measure characteristic of a homeopathic preparation that affects the expression of at least one gene, the method comprising contacting the preparation with a gene in a gene expression system; and measuring the level of expression of the gene; wherein the level of expression constitutes the measure characteristic of the contents of the preparation.

US Patent:

47862947, Nov 22, 1988

Filed:

Dec 21, 1987

Appl. No.:

7/135872

Inventors:

Michel A. Jonqueres - Torrance CA
Robert J. Kay - Redondo Beach CA

Assignee:

Allied-Signal Inc. - Morris Township, Morris County NJ

International Classification:

B01D 5304

US Classification:

55 28

Abstract:

An integrated system for removal of CO. sub. 2 from and thermal conditioning of a gas mixture is disclosed. A pair of regenerating chemically impregnated molecular sieve absorption beds are used for removal of the CO. sub. 2. A heat exchanger used in the thermal conditioning subsystem also heats the gas used to regenerate the beds and cools absorption gas. A recirculation fan moves the gas mixture throughout the entire thermal conditioning and gas purification system.